Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Artif Cells Nanomed Biotechnol ; 46(sup3): S1076-S1082, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30449264

RESUMEN

Red blood cells (RBCs) possess intact cyto-architectures while haemoglobin (Hb) is a cell-free, homogeneous solution. Both RBCs and Hb are generalized oxygen carriers. In this paper, kinetic studies on oxygen-releasing of high concentration of Hb and RBCs under various conditions were carried out regarding Hb and RBCs as fluids. Among them, Hb under specific conditions was seen as the simplest Hb-based oxygen carrier (HBOC), Also, factors affecting the oxygen releasing of Hb and RBCs, including osmotic pressure, viscosity and allosteric agent, have been well studied. Analysis of the results from the measurement above showed that kinetics of oxygen releasing of either pure Hb or the simplest HBOCs was obviously different from that of RBCs. The oxygen-releasing time of Hb was shorter and the oxygen-releasing rates of Hb were quicker than those of RBCs under various conditions. Therefore, as fluids, only by changing the milieus it exists in, Hb could not achieve the expected oxygen-releasing effect on the microcirculation so well as RBCs do in the same system, irrespective of the interaction between the fluids and blood vessels. Furthermore, kinetic properties of HBOCs must be considered and matched with those of RBCs in the study of HBOCs.


Asunto(s)
Sustitutos Sanguíneos , Eritrocitos/metabolismo , Hemoglobinas , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Oxígeno , Sustitutos Sanguíneos/farmacocinética , Sustitutos Sanguíneos/farmacología , Eritrocitos/citología , Hemoglobinas/farmacocinética , Hemoglobinas/farmacología , Células Endoteliales de la Vena Umbilical Humana/citología , Humanos , Oxígeno/química , Oxígeno/farmacocinética , Oxígeno/farmacología
2.
Artif Cells Nanomed Biotechnol ; 44(4): 1075-9, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26838267

RESUMEN

The application of hemoglobin-based oxygen carriers (HBOCs) remains stagnant because a large number of reactive oxygen species (ROS) will be produced in organisms when HBOCs are used. Ferulic acid (FA) has a known effect on quenching oxygen free radicals and relieving vasospasm. Thus a kind of FA modified hemoglobin (BAEGF-Hb) is expected to produce the anti-oxidation effect on HBOCs spontaneously, and reduce toxicity. Isoelectric focusing electrophoresis, UV-vis wavelength scanning, and oxygen affinity curve showed that hemoglobin (Hb) was successfully modified and this modification had no effect on the structure of Hb and P50. The modification degree of Hb is 4.


Asunto(s)
Sustitutos Sanguíneos/química , Sustitutos Sanguíneos/síntesis química , Ácidos Cumáricos/química , Hemoglobinas/química , Humanos , Oxidación-Reducción , Oxígeno/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...